Click Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesHealthcare Software · New York, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
80 White St Fl 3, New York City, New Yor...Phone Number
(646) 248-7933Website
www.clicktherapeutics.comRevenue
$29.8 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
4
4
5
3
2
About Click Therapeutics
Click Therapeutics is a digital health company that develops software-based prescription treatments delivered through mobile applications. It combines neuroscience and technology to create clinically validated digital therapeutics designed to improve patient outcomes and expand access to care. The company focuses on addressing unmet medical needs by providing regulated, evidence-based treatments that integrate into modern healthcare systems.Explore more
Click Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Click Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Click Therapeutics launches new products
Click to see if Click Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Click Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Click Therapeutics recently announced quarterly report
Check out if Click Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Click Therapeutics
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Click Therapeutics has new funding data
Click Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Click Therapeutics
Find more new buyers
Compare Similar Companies to Click Therapeutics
Compare insights from companies similar to Click Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$13M
51-200
Private
-
2006
Company Profile Activity
Activity Insights
Click Therapeutics is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Click Therapeutics is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Click Therapeutics.
Click Therapeutics financials insights
Gather financial insights about Click Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$19M
2020
Debt
$350K
Debt
$30M
2021
Series B
$52M
2022
Debt
$15M
2023
Debt
$20M
2025
Other Financing Round
$48.5M
2026
Series D
$50M
Click Therapeutics Tech Stack
A closer look at the technologies used by Click Therapeutics
Most Recent Scoops
Event
Product Marketing, Events, Sales, Digital Technology, Software, Field /Outside Sales, Field Marketing, Healthcare Operations, Healthcare Technology, Operations, Patient Experience, Telemedicine
Person-Based
Clinical Operations
Open Position
Open Position
Open Position
Click Therapeutics News & Media
Click Therapeutics and Boehringer Ingelheim Announce Series D Investment and Funding to Advance Commercialization of CT-155
INGELHEIM, Germany and RIDGEFIELD, Connecticut and NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- Boehringer Ingelheim and Click Therapeutics today announced a strategic agreement to support the commercialization of CT-155, an investigational prescription digital therapeutic that is being studied for the treatment of the experiential negative symptoms of schizophrenia in adults aged 18 years and older.3 Under the agreement, Boehringer will transfer full product responsibility, including all commerUltrahuman and Click Therapeutics partner to launch the world’s first biomarker-driven migraine management tool based on FDA-authorized technology
Partnership brings the proprietary technology behind Click’s FDA-authorized digital migraine intervention to the Ultrahuman platform Partnership brings the proprietary technology behind Click’s FDA-authorized digital migraine intervention to the Ultrahuman platformBoehringer and Click Therapeutics present pivotal data for investigational prescription digital therapeutic CT-155 showing a statistically significant reduction in negative symptoms of schizophrenia
CONVOKE was the first and only pivotal trial to show a statistically significant reduction in experiential negative symptoms of schizophrenia as an adjunct to standard of care antipsychotic therapy, as presented at ECNP Congress1 Treatment with CT-155 demonstrated a Cohen's D effect size...Boehringer and Click Therapeutics’ investigational prescription digital therapeutic CT-155 meets primary endpoint in CONVOKE study for negative symptoms in schizophrenia
Ingelheim, Germany / Ridgefield, Connecticut / New York, New York
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Click Therapeutics
Sign Up For FreeTo access detailed company insights
Click Therapeutics is a digital health company that develops software-based prescription treatments delivered through mobile applications. It combines neuroscience and technology to create clinically validated digital therapeutics designed to improve patient outcomes and expand access to care. The company focuses on addressing unmet medical needs b... Read More
